FDA No Longer Supports Compounded Pergolide Production

  • Print
  • Email
  • Favorite
  • Share
  • Newsletters

The U.S. FDA will no longer support the production of compounded pergolide for use in horses. The change comes several months after the FDA approved a pergolide mesylate tablet for the treatment of clinical signs associated with PPID in horses.

To continue reading this article, become a member of TheHorse.com.

It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.

Sign In
Stay on top of the most recent Horse Health news with FREE weekly newsletters from TheHorse.com. Learn More

Free Newsletters

Sign up for the latest in:

From our partners